Dendrimer scaffolds for pharmaceutical use
US9359392B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2013 |
| Grant date | Jun 7, 2016 |
| Priority date | — |
| Expiry date | Sep 5, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C237/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to certain dendrimer compounds. In particular, this invention relates to novel dendrimer compounds that can be elaborated to give increasingly large and complex compounds. These elaborated compounds can be attached to, or can encapsulate within, active agent(s) so as to beneficially modify the characteristics of that active agent. Alternatively, the elaborated compounds can themselves be beneficially modified into therapeutic agents by the attachment of inactive agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.